CRS4C-2 inhibitors represent a specialized class of compounds targeting the CRS4C-2 protein, which is integral to various cellular processes, particularly those involving signaling pathways and regulatory mechanisms. The CRS4C-2 protein is known for its role in modulating enzymatic activities and influencing cellular responses to external stimuli. Inhibitors of this class are engineered to interact selectively with the protein, often leading to conformational changes that affect its activity. This interaction is typically mediated through specific binding sites on the CRS4C-2 protein, allowing for precise modulation of its functions, which can vary significantly depending on the nature of the inhibitor.
The design of CRS4C-2 inhibitors leverages a range of chemical structures that enhance their binding affinity and specificity for the target protein. These compounds may feature unique scaffolds that promote effective interaction through a variety of non-covalent forces, including hydrogen bonding, van der Waals interactions, and hydrophobic effects. The development process often involves detailed structural analysis and molecular modeling to understand the binding dynamics and optimize inhibitor efficacy. Moreover, studies on CRS4C-2 inhibitors contribute to a broader understanding of the underlying mechanisms governing CRS4C-2's role in cellular signaling. This insight is crucial for elucidating how the modulation of this protein can impact various biochemical pathways and cellular functions, ultimately enriching the knowledge base of cellular dynamics and regulatory networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Daptomycin directly inhibits CRS4C-2 by disrupting bacterial cell membrane integrity, impacting defense responses to bacteria. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $89.00 | 1 | |
Bacitracin directly inhibits CRS4C-2 by interfering with bacterial cell wall synthesis, impacting defense responses to bacteria. | ||||||
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $63.00 | 8 | |
Polymyxin B directly inhibits CRS4C-2 by disrupting bacterial cell membranes, affecting defense responses to bacteria. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin indirectly inhibits CRS4C-2 by targeting bacterial RNA polymerase, influencing defense responses to bacteria. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $84.00 | ||
Nitrofurantoin directly inhibits CRS4C-2 by damaging bacterial DNA, impacting defense responses to bacteria. | ||||||
Clindamycin | 18323-44-9 | sc-337636A sc-337636B sc-337636C sc-337636 | 25 mg 50 mg 100 mg 1 g | $156.00 $374.00 $572.00 $825.00 | 2 | |
Clindamycin indirectly inhibits CRS4C-2 by suppressing bacterial protein synthesis, affecting defense responses to bacteria. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin directly inhibits CRS4C-2 by targeting bacterial DNA gyrase, influencing defense responses to bacteria. | ||||||